FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Priority Review for Roche Enspryng sBLA

FDA grants a priority review for a Roche sBLA for Espryng to treat myelin oligodendrocyte glycoprotein antibody-associated disease, an autoimmune dise...

latest-news-card-1
Medical Devices

BMC Medical Recalls Sleep Apnea Machines

BMC Medical recalls its Luna G3 APAP (Model LG3600), an auto-adjusting positive airway pressure machine for treating obstructive sleep apnea, due to a...

latest-news-card-1
Human Drugs

FDA Partial Clinical Hold on Biohaven Epilepsy Drug

FDA issues a partial clinical hold on Biohavens opakalim (BHV-7000) due to nonclinical characterization of certain metabolites documented in rodent te...

latest-news-card-1
Human Drugs

3 Observations on XeCare FDA-483

FDA releases the Form FDA-483 with three observations from an inspection at New Albany, OH-based XeCare.

latest-news-card-1
Human Drugs

FDA Open to Alternative Approaches For Psychedelic Drug Trials

Writing in a in a New England Journal of Medicine article, FDA officials encourage novel approaches for developing psychedelic drugs for mental health...

latest-news-card-1
Human Drugs

Bill to Update FDA Drug Preclusion Rules

Rep. Diana Harshberger introduces legislation to aid the dietary supplement industry by changing FDAs drug preclusion rules.

latest-news-card-1
Human Drugs

Reduced Application Fees Not Sufficient Incentive: Column

Ovid Therapeutics executive chairman Jeremy Levin says FDA needs to speed its regulatory processes if it wants to persuade companies to conduct Phase ...

latest-news-card-1
Human Drugs

Bayer Gets OK for Lung Cancer Drug

FDA grants Bayer an accelerated approval for Hyrnuo (sevabertinib), a kinase inhibitor for certain adult patients with locally advanced or metastatic ...

Human Drugs

FDA Still Reviewing Rezolute Phase 3 Info

Rezolute says FDA is still reviewing the additional data the agency requested from the companys Phase 3 sunRIZE trial of ersodetug to treat hypoglycem...

latest-news-card-1
Biologics

Nanoscope BLA Accepted for Vision Restoration Gene Therapy

FDA accepts for review a Nanoscope Therapeutics BLA seeking approval for Mogenry, an optogenetic gene therapy designed for vision restoration in patie...